Ethiofos en es it fr

Ethiofos Brand names, Ethiofos Analogs

Ethiofos Brand Names Mixture

  • No information avaliable

Ethiofos Chemical_Formula

C5H15N2O3PS

Ethiofos RX_link

http://www.rxlist.com/cgi/generic/amifostine.htm

Ethiofos fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=118

Ethiofos msds (material safety sheet)

Ethiofos MSDS

Ethiofos Synthesis Reference

No information avaliable

Ethiofos Molecular Weight

214.224 g/mol

Ethiofos Melting Point

No information avaliable

Ethiofos H2O Solubility

1000 mg/mL

Ethiofos State

Solid

Ethiofos LogP

-1.043

Ethiofos Dosage Forms

Powder for solution

Ethiofos Indication

For reduction in the cumulative renal toxicity in patients with ovarian cancer (using cisplatin) and moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.

Ethiofos Pharmacology

Amifostine is an organic thiophosphate cytoprotective agent indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer or non-small cell lung cancer and also to reduce the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer. Amifostine is a prodrug that is dephosphorylated by alkaline phosphatase in tissues to a pharmacologically active free thiol metabolite, believed to be responsible for the reduction of the cumulative renal toxicity of cisplatin and for the reduction of the toxic effects of radiation on normal oral tissues. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

Ethiofos Absorption

No information avaliable

Ethiofos side effects and Toxicity

Rat LD50: 826 mg/kg

Ethiofos Patient Information

No information avaliable

Ethiofos Organisms Affected

Humans and other mammals